NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

3M Submits 510(k) Application for BI System

3M has filed for 510(k) clearance with the U.S. Food and Drug Administration (FDA) for an additional indication for its Attest Rapid Biological Indicator (BI) System for vaporized hydrogen peroxide sterilization (VH202) to provide BI test results in just 24 minutes. Pending clearance, the 24-minute results are anticipated to be the fastest BI readout on the market for VH202 sterilization and will make the practice of every load monitoring increasingly feasible.

“Every minute counts when it comes to patient safety,” said Cindy Kent from the 3M Infection Prevention Division. “Central sterile departments deserve simple and effective solutions to help minimize the risk of healthcare acquired infections from surgical instruments. Faster BI readout times can increase feasibility to monitor every sterilization load, helping to provide ultimate confidence that every patient receives the same high standard of care.”

A 24-minute result would be a significant advancement over 3M’s current market-leading time of four hours, achieved with the 2016 release of the 3M Attest Rapid Biological Indicator System for VH202. With a continued focus on system enhancements following the 4-hour readout launch, 3M scientists were able to increase system capabilities including a faster readout time.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X